Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: Pechala's Reports
$15.00
Provider: Pechala's Reports
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Dr.Reddy's Laboratories Ltd Announces Approval of Azacitidine for Injection


Tuesday, 17 Sep 2013 02:13am EDT 

Dr.Reddy's Laboratories Ltd announced that Azacitidine for injection 100 mg/vial, a bioequivalent generic version of VIDAZA is approved by the USFDA on September 16, 2013. 

Latest Key Developments in Pharmaceuticals

Company Quote

44.7
0.89 +2.03%
11 Jul 2014